MGP reaffirms 2026 adjusted EBITDA $90M-$98M as Sempreon rebrand approaches (NASDAQ:MGPI)

MGP Ingredients (MGPI) reported Q3 2026 earnings, reducing debt by $28M and achieving a 3.6x leverage ratio. The company will rebrand to Sempraan, trading on NASDAQ under CASK. Q3 sales for Branded Spirits were $58.2M, down 4% YoY, while Distilling Solutions sales were $29M, down 29% YoY. The company expects continued growth and introduced new products and leadership frameworks.

MGP Ingredients (MGPI) reported Q3 2026 adjusted EPS of $0.39, beating estimates by 21.88%, but revenue of $117.9M missed forecasts. The company announced a rebrand to Sempreon, trading under CASK. Stock rose 4.08% premarket. Full-year guidance was reaffirmed.

MGP Ingredients reported Q3 2026 revenue of $117.9 million, missing estimates by 2.2%, but beat EPS estimates by 21.1%. Adjusted EBITDA missed slightly. Full-year guidance was reconfirmed, with EBITDA expected to exceed estimates. Operating margin declined, while free cash flow margin improved.

MGP Ingredients (MGPI) reported Q3 EPS of $0.39, beating estimates by $0.07, but revenue of $117.9M missed expectations. The company forecasted FY 2026 EPS of $1.50-$1.80 and revenue of $480M-$500M, both below analyst consensus. The stock is down 13.45% in the last 3 months and 37.95% year-over-year.

MGP Ingredients reported Q3 Non-GAAP EPS of $0.39, beating estimates by $0.07. Revenue fell 9.9% year-over-year to $117.9M, missing expectations. Adjusted EBITDA declined 33% to $21.5M. The company reaffirmed its FY26 outlook despite these results.

MGP Ingredients reported Q3 2026 sales of $117.9M, down 10% YoY, with net income of $6.9M. Adjusted EPS was $0.39, down from $0.85. The company reaffirmed its 2026 outlook and announced a name change to Sempreon on November 2. Sales growth was seen in Penelope Bourbon and mid-priced brands, while Distilling Solutions faced market challenges. Ingredient Solutions saw growth in specialty wheat proteins.